Association of the apolipoprotein E ε4 allele in a Serbian population with Alzheimer’s dementia

Although single nucleotide polymorphisms rs429358 and rs7412 in the apolipoprotein E gene (APOE) are widely investigated to analyze APOE alleles, there are no data on their association with Alzheimer’s disease (AD) dementia in a Serbian population. This study aimed to investigate the distribution of...

Full description

Bibliographic Details
Main Authors: Bašić Jelena, Milošević Vuk, Đorđević Branka, Stefanović Nikola, Cvetković Marija, Jevtović-Stoimenov Tatjana, Stojanović Ivana
Format: Article
Language:English
Published: University of Belgrade, University of Novi Sad 2023-01-01
Series:Archives of Biological Sciences
Subjects:
Online Access:https://doiserbia.nb.rs/img/doi/0354-4664/2023/0354-46642300026B.pdf
Description
Summary:Although single nucleotide polymorphisms rs429358 and rs7412 in the apolipoprotein E gene (APOE) are widely investigated to analyze APOE alleles, there are no data on their association with Alzheimer’s disease (AD) dementia in a Serbian population. This study aimed to investigate the distribution of APOE ε2/ε3/ε4 alleles in patients with dementia due to AD and cognitively unimpaired subjects and to assess the association of the APOE ε4 allele with disease risk in the Serbian population. A case-control study included patients with dementia due to AD and cognitively unimpaired individuals. APOE rs429358 and rs7412 were analyzed using the Real-Time PCR method with allele-specific TaqMan assays, followed by APOE ε2/ε3/ε4 allele carrier status analysis. Patients had a significantly higher frequency of the APOE ε4 allele than the control group (P<0.001). The APOE ε4 allele was found to be associated with a 3-fold higher risk of AD dementia compared to the reference ε3 allele (P<0.001). In conclusion, this is the first study to suggest that carriers of the APOE ε4 allele have a higher risk of developing dementia due to AD than those who carry the APOE ε3 allele in the Serbian population.
ISSN:0354-4664
1821-4339